Co.don
| co.don Aktiengesellschaft
|
|
|---|---|
 |
|
| legal form | Corporation |
| ISIN | DE000A1K0227 |
| founding | 1993 |
| Seat |
Teltow , Germany
|
| management |
|
| Number of employees | 92 |
| sales | 5.654 million euros (2018) |
| Branch | biotechnology |
| Website | www.codon.de |
| As of December 31, 2018 | |
The co.don AG (proper spelling: co.don) is a German biopharmaceutical company based in Teltow . The company's core business is the development, manufacture and marketing of cell therapies for the treatment of articular cartilage defects .
history
The company was founded in 1993 to develop novel therapies and drugs that are based exclusively on the body's own cartilage cells .
On February 14, 2001, the company went public on the Neuer Markt of the Frankfurt Stock Exchange . The expansion into the USA was to be financed with the proceeds from the IPO.
The “cell culture process” developed by the company has been adopted by health insurance companies since 2007 and is used, for example, in the Asklepios clinics . In July 2017, the cartilage product Spherox received EU-wide approval.
By 2019 the company had invested around 14 million euros in Bio City Leipzig .
Share and shareholders
The company's share is listed in the General Standard and included in the CDAX . The company's share capital is divided into around 21.7 million shares . For shareholders with reportable shares see table:
| proportion of | Shareholders |
|---|---|
| 25.00% | Prof. Hans B. Bauerfeind on Bauerfeind Beteiligungsgesellschaft mbH |
| 6.90% | Beatrix Bauerfeind-Johnson through BBJ Beteiligungsgesellschaft mbH |
As of May 10, 2019
Web links
Individual evidence
- ↑ commercial register of co.don Aktiengesellschaft from Teltow (HRB 12948 P). In: www.online-handelsregister.de. Retrieved October 16, 2019 .
- ↑ co.don AG, Teltow - Company information. In: www.firmenwissen.de. Retrieved October 16, 2019 .
- ↑ co.don AG, Teltow. In: www.northdata.de. Retrieved October 16, 2019 .
- ↑ a b Management. In: www.codon.de. Retrieved October 16, 2019 .
- ↑ a b Annual Report 2018. (pdf) In: www.codon.de. Retrieved October 16, 2019 .
- ↑ co.don: IPO headwind. In: www.manager-magazin.de. Retrieved October 16, 2019 .
- ↑ A year earlier than previously planned: Codon wants to enter the US market faster with its IPO. In: www.handelsblatt.com. Retrieved October 16, 2019 .
- ^ A b Claas Tatje, Laura Cwiertnia, Felix Rohrbeck: Aktien: Co.don . In: The time . December 27, 2017, ISSN 0044-2070 ( zeit.de [accessed October 16, 2019]).
- ^ Süddeutsche Zeitung: Kramp-Karrenbauer recognizes Saxony as an innovation location. Retrieved October 16, 2019 .
- ↑ share information: co.don AG. In: www.boerse-frankfurt.de. Retrieved October 16, 2019 .
- ↑ The CO.DON share. In: www.codon.de. Retrieved October 16, 2019 .
- ↑ BaFin - Significant shares of voting rights according to Sections 33, 38 and 39 of the Securities Trading Act (WpHG). Retrieved October 16, 2019 .